Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

-Stephen Brown PhD FRPharmS, Pharmaceutical and Biotech Consultant

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The World Health Organization classified the COVID-19 outbreak as a pandemic in early March 2020 as the disease reached most areas of the world, infecting hundreds of thousands of people and killing thousands.

Click here to be emailed a copy of our whitepaper